A cash-rich stock I’d buy alongside Taylor Wimpey (TW) shares

Taylor Wimpey (LON: TW) shares are climbing, but this stock is doing even better.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’ve seen some interesting housing figures published in recent days, based on 2019 housing studies. They suggest we have a housing shortage of between 1 million and 1.2 million homes.

EU negotiations could fail and we could hit a recession that depresses mortgage demand. But even then I don’t expect a serious house price slump. And these results definitely reinforce my conviction that there are some great buys among housebuilder stocks.

That thought was boosted further Monday morning by Berkeley Group Holdings (LSE: BKG). Berkeley’s shares are up 39% over the past 12 months, even with the firm’s focus on the more expensive markets of London and the South East. And there’s a 5% dividend on the cards too.

Capital return

But that’s not the end to the rewards Berkeley shareholders can expect. The company has revealed a new capital return plan. Berkeley now intends to return £1bn to shareholders over the next two years, an increase of £455m over previous ambitions.

It is, somewhat confusingly, going to be done via a B share issue and buyback offer in March 2020. The scheme will also entail a 92.69 for 100 consolidation of existing shares. And there will be something similar in March 2021 via a C share scheme. But the bottom line is a £500m return in March 2020, and the same in March 2021.

The shares dipped a little, but that could be partly due to the complexity of the capital return plan. Then again, the whole Footsie is down, so it’s hard to determine what investors are thinking. Whatever the reason, I rate Berkeley Group as a buy

UK’s biggest

Meanwhile, the Taylor Wimpey (LSE: TW) share price is up 35% over 12 months. That’s almost as far as Berkeley’s — though over five years, Berkeley is well ahead of TW, which is the country’s biggest FTSE 100 housebuilder.

Full-year results should be with us on Wednesday. Chief executive Pete Redfern has already told us that “results for the year to 31 December 2019 will be in line with our expectations.” Completions rose by 5% during the year, though the company seems to be sensibly focused on the long term. Redfern added: “In 2019, our focus was on strengthening the long-term sustainability of the business, further improving our build quality and customer offering, as well as increasing operating capacity and flexibility.”

And despite the economic uncertainty and investors’ fears of a housing slowdown, TW says the market remained stable throughout the year.

Cash

The key thing for me is that Taylor Wimpey is also generating cash strongly and is paying handsome dividends to shareholders. The predicted yield for 2019 stands at 7.8% at the moment, and forecasts see that reaching 8% by 2021.

Despite that, I think we could see some share price weakness through 2020. Uncertainty does tend to have a disproportionate impact on housebuilder shares. I guess part of it is that, by their very nature, they don’t offer global diversification the way others do.

So Taylor Wimpey is UK-centric. And that allegedly means it’s risky while we edge a bit closer to Brexit brinkmanship every day. But when investors are fearful, that’s the time to be greedy. It’s another buy for me.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »